Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, whether his Department has a policy on standardising the dose branding of aseptic pharmaceutical products across all health trusts.

The Medicines and Healthcare products Regulatory Agency is working with other groups to promote the risk-reducing benefits of dose banding.

NHS England, through its Medicines Optimisation Clinical Reference Group work programme, is working with key stakeholders to identify/agree national standard dose bands for chemotherapy. A national Commissioning for Quality and Innovation goal has been agreed to support the implementation of the dose bands during 2017-18.